Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 73 articles: HTML format

Single Articles

February 2024
1. RANDOLPH SD, Johnson R
   A Salon-Based Intervention to Improve PrEP Uptake among Black Women.
   N Engl J Med. 2024;390:776-777.
   PubMed    
   
   
   
2. DICKTER JK, Aribi A, Cardoso AA, Gianella S, et al
   HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation.
   N Engl J Med. 2024;390:669-671.
   PubMed    
   
   
   
3. FORD N, Ehrenkranz P, Jarvis J
   Advanced HIV as a Neglected Disease.
   N Engl J Med. 2024;390:487-489.
   PubMed    
   
   
   January 2024
4. DONOVAN J, Phu NH, Thwaites GE
   Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults. Reply.
   N Engl J Med. 2024;390:383.
   PubMed    
   
   
   
5. ELLIS J, Meya DB, Cresswell FC
   Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
   N Engl J Med. 2024;390:382-383.
   PubMed    
   
   
   
6. STAFFORD IA, Workowski KA, Bachmann LH
   Syphilis Complicating Pregnancy and Congenital Syphilis.
   N Engl J Med. 2024;390:242-253.
   PubMed    
   
   
   December 2023
7. MARRAZZO J
   Doxycycline Postexposure Prophylaxis for STIs in Women - Uncertain Benefit, Urgent Need.
   N Engl J Med. 2023;389:2389-2390.
   PubMed    
   
   
   
8. STEWART J, Oware K, Donnell D, Violette LR, et al
   Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
   N Engl J Med. 2023;389:2331-2340.
   PubMed     Abstract available
   
   
   
9. MOROTI CONSTANTINESCU VR
   Acute Human Immunodeficiency Virus Infection.
   N Engl J Med. 2023;389:2276.
   PubMed    
   
   
   November 2023
10. GRINSPOON SK, Ribaudo HJ, Douglas PS
    Pitavastatin and Cardiovascular Disease in HIV. Reply.
    N Engl J Med. 2023;389:e46.
    PubMed    
    
    
    
11. OLALLA J, Pombo M
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.
    PubMed    
    
    
    
12. IOANNOU P, Filippatos TD, Kofteridis DP
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.
    PubMed    
    
    
    
13. ALAM SR, Mureithi M, Ferrand R
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.
    PubMed    
    
    
    
14. BOETTIGER DC, Phillips AN, Newall AT
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.
    PubMed    
    
    
    October 2023
15. DONOVAN J, Bang ND, Imran D, Nghia HDT, et al
    Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
    N Engl J Med. 2023;389:1357-1367.
    PubMed     Abstract available
    
    
    September 2023
16. ABDOOL KARIM SS, Barre-Sinoussi F, Varmus HE, Serwadda D, et al
    Threatening the Global AIDS Response - Obstacles to PEPFAR's Reauthorization.
    N Engl J Med. 2023;389:1159-1161.
    PubMed    
    
    
    August 2023
17. LO NC, Gonsalves GS
    Outbreaks in U.S. Migrant Detention Centers - A Vaccine-Preventable Cause of Health Inequity.
    N Engl J Med. 2023;389:679-681.
    PubMed    
    
    
    
18. 
    Preventing HIV's Collateral Cardiovascular Damage.
    N Engl J Med. 2023;389:e11.
    PubMed    
    
    
    
19. GODFREY C, Nkengasong J
    Prioritizing Mental Health in the HIV/AIDS Response in Africa.
    N Engl J Med. 2023;389:581-583.
    PubMed    
    
    
    
20. KRAKOWER D, Marcus JL
    Free the PrEP - Over-the-Counter Access to HIV Preexposure Prophylaxis.
    N Engl J Med. 2023 Aug 5. doi: 10.1056/NEJMp2305644.
    PubMed    
    
    
    July 2023
21. GRINSPOON SK, Fitch KV, Zanni MV, Fichtenbaum CJ, et al
    Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
    N Engl J Med. 2023 Jul 23. doi: 10.1056/NEJMoa2304146.
    PubMed     Abstract available
    
    
    
22. FREIBERG MS
    HIV and Cardiovascular Disease - An Ounce of Prevention.
    N Engl J Med. 2023 Jul 23. doi: 10.1056/NEJMe2306782.
    PubMed    
    
    
    
23. NACHEGA JB, Serwadda D, Abimiku A, Sikazwe I, et al
    PEPFAR at 20 - A Game-Changing Impact on HIV in Africa.
    N Engl J Med. 2023;389:1-4.
    PubMed    
    
    
    June 2023
24. OMBAJO LA, Penner J, Nkuranga J, Mecha J, et al
    Second-Line Switch to Dolutegravir for Treatment of HIV Infection.
    N Engl J Med. 2023;388:2349-2359.
    PubMed     Abstract available
    
    
    
25. OGOINA D, James HI
    Mpox among Linked Heterosexual Casual Partners in Bayelsa, Nigeria.
    N Engl J Med. 2023;388:2101-2104.
    PubMed    
    
    
    May 2023
26. DEPUTY NP, Deckert J, Chard AN, Sandberg N, et al
    Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
    N Engl J Med. 2023 May 18. doi: 10.1056/NEJMoa2215201.
    PubMed     Abstract available
    
    
    
27. LISCO A, Ortega-Villa AM, Mystakelis H, Anderson MV, et al
    Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
    N Engl J Med. 2023;388:1680-1691.
    PubMed     Abstract available
    
    
    April 2023
28. LUETKEMEYER AF, Donnell D, Dombrowski JC, Cohen S, et al
    Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
    N Engl J Med. 2023;388:1296-1306.
    PubMed     Abstract available
    
    
    March 2023
29. 
    The Fauci Phenomenon, Part 2.
    N Engl J Med. 2023;388:e40.
    PubMed    
    
    
    
30. 
    The Fauci Phenomenon.
    N Engl J Med. 2023;388:e28.
    PubMed    
    
    
    
31. JOHNSON J, Killelea A, Farrow K
    Investing in National HIV PrEP Preparedness.
    N Engl J Med. 2023;388:769-771.
    PubMed    
    
    
    February 2023
32. PATON NI, Cousins C, Suresh C, Burhan E, et al
    Treatment Strategy for Rifampin-Susceptible Tuberculosis.
    N Engl J Med. 2023 Feb 20. doi: 10.1056/NEJMoa2212537.
    PubMed     Abstract available
    
    
    January 2023
33. EKE AC, Mirochnick M, Lockman S
    Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV.
    N Engl J Med. 2023;388:344-356.
    PubMed    
    
    
    December 2022
34. NYANG'WA BT, Berry C, Kazounis E, Motta I, et al
    A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
    N Engl J Med. 2022;387:2331-2343.
    PubMed     Abstract available
    
    
    
35. KIEH M, Richert L, Beavogui AH, Grund B, et al
    Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
    N Engl J Med. 2022 Dec 14. doi: 10.1056/NEJMoa2200072.
    PubMed     Abstract available
    
    
    November 2022
36. AKIYAMA MJ, Spaulding AC, Nijhawan AE
    Long-Acting Injectable Antiretrovirals in Incarcerated Populations - Challenges and Opportunities.
    N Engl J Med. 2022;387:1728-1730.
    PubMed    
    
    
    
37. CHEMAITELLY H, AlMukdad S, Ayoub HH, Altarawneh HN, et al
    Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
    N Engl J Med. 2022 Nov 2. doi: 10.1056/NEJMoa2210058.
    PubMed     Abstract available
    
    
    September 2022
38. COLLIE S, Nayager J, Bamford L, Bekker LG, et al
    Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210093.
    PubMed    
    
    
    
39. ANDERSON AS, Caubel P, Rusnak JM
    Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2205944.
    PubMed    
    
    
    
40. CONRADIE F, Bagdasaryan TR, Borisov S, Howell P, et al
    Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
    N Engl J Med. 2022;387:810-823.
    PubMed     Abstract available
    
    
    
41. PATEL K, Huo Y, Jao J, Powis KM, et al
    Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.
    N Engl J Med. 2022;387:799-809.
    PubMed     Abstract available
    
    
    August 2022
42. MARCUS JL, Killelea A, Krakower DS
    HIV Prevention and the 340B Drug Pricing Program. Reply.
    N Engl J Med. 2022;387:576.
    PubMed    
    
    
    
43. HALL CS
    HIV Prevention and the 340B Drug Pricing Program.
    N Engl J Med. 2022;387:575-576.
    PubMed    
    
    
    July 2022
44. THORNHILL JP, Barkati S, Walmsley S, Rockstroh J, et al
    Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
    N Engl J Med. 2022 Jul 21. doi: 10.1056/NEJMoa2207323.
    PubMed     Abstract available
    
    
    June 2022
45. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    PubMed     Abstract available
    
    
    
46. ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
    Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
    PubMed     Abstract available
    
    
    
47. MARCUS JL, Killelea A, Krakower DS
    Perverse Incentives - HIV Prevention and the 340B Drug Pricing Program.
    N Engl J Med. 2022;386:2064-2066.
    PubMed    
    
    
    May 2022
48. MARRAZZO J
    Lenacapavir for HIV-1 - Potential Promise of a Long-Acting Antiretroviral Drug.
    N Engl J Med. 2022;386:1848-1849.
    PubMed    
    
    
    
49. SEGAL-MAURER S, DeJesus E, Stellbrink HJ, Castagna A, et al
    Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
    N Engl J Med. 2022;386:1793-1803.
    PubMed     Abstract available
    
    
    
50. GRAY G, Collie S, Goga A, Garrett N, et al
    Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
    PubMed    
    
    
    April 2022
51. MOORE PL, Baden LR
    Omicron - Decoupling Infection from Severe Disease.
    N Engl J Med. 2022;386:1361-1362.
    PubMed    
    
    
    March 2022
52. JARVIS JN, Lawrence DS, Meya DB, Kagimu E, et al
    Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    N Engl J Med. 2022;386:1109-1120.
    PubMed     Abstract available
    
    
    
53. LUEKING R, Lazarte S
    Malignant Syphilis.
    N Engl J Med. 2022;386:e26.
    PubMed    
    
    
    
54. OZELO MC, Mahlangu J, Pasi KJ, Giermasz A, et al
    Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
    N Engl J Med. 2022;386:1013-1025.
    PubMed     Abstract available
    
    
    
55. TURKOVA A, Wills GH, Wobudeya E, Chabala C, et al
    Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.
    N Engl J Med. 2022;386:911-922.
    PubMed     Abstract available
    
    
    
56. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, AlMukdad S, et al
    Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMoa2200797.
    PubMed     Abstract available
    
    
    February 2022
57. SILVERMAN RF, Shinder R
    Molluscum Contagiosum.
    N Engl J Med. 2022;386:582.
    PubMed    
    
    
    January 2022
58. ATMAR RL, Lyke KE, Deming ME, Jackson LA, et al
    Homologous and Heterologous Covid-19 Booster Vaccinations.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMoa2116414.
    PubMed     Abstract available
    
    
    December 2021
59. TURKOVA A, White E, Mujuru HA, Kekitiinwa AR, et al
    Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
    N Engl J Med. 2021;385:2531-2543.
    PubMed     Abstract available
    
    
    
60. COLLIE S, Champion J, Moultrie H, Bekker LG, et al
    Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119270.
    PubMed    
    
    
    
61. CATTAMANCHI A, Reza TF, Nalugwa T, Adams K, et al
    Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
    N Engl J Med. 2021;385:2441-2450.
    PubMed     Abstract available
    
    
    
62. BOR J, Onoya D, Richman B, Mayer KH, et al
    A Failure to Disseminate Transformative Science - HIV Treatment as Prevention, 10 Years On.
    N Engl J Med. 2021;385:2305-2307.
    PubMed    
    
    
    
63. BRAVO MS
    Emperor of the Empire.
    N Engl J Med. 2021;385:2215-2217.
    PubMed    
    
    
    November 2021
64. DIETZ BW, Winston LG, Koehler JE, Margaretten M, et al
    Copycat.
    N Engl J Med. 2021;385:1797-1802.
    PubMed    
    
    
    October 2021
65. TSENG ZH, Hsue PY, Moffatt E
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV. Reply.
    N Engl J Med. 2021;385:e50.
    PubMed    
    
    
    
66. OLALLA J, Pombo M
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed    
    
    
    
67. KLEIN MD, Keen SK, Simpson RJ Jr
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed    
    
    
    
68. CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
    Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
    PubMed     Abstract available
    
    
    September 2021
69. SAAG MS
    HIV Infection - Screening, Diagnosis, and Treatment. Reply.
    N Engl J Med. 2021;385:1344.
    PubMed    
    
    
    
70. DE SOCIO GV
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;385:1344.
    PubMed    
    
    
    
71. LEINER S
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;385:1343-1344.
    PubMed    
    
    
    
72. BAYER R, Oppenheimer GM, Parisi V
    Marking the 40th Anniversary of the AIDS Epidemic - American Physicians Look Back.
    N Engl J Med. 2021;385:1251-1253.
    PubMed    
    
    
    
73. GOUVEIA-MORAES F, Campos N
    Conjunctival Kaposi's Sarcoma.
    N Engl J Med. 2021;385:e36.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.